ID   KML1-7
AC   CVCL_4J74
DR   Wikidata; Q54900123
RX   Patent=US5132222;
RX   PubMed=2197220;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 86091801.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000027.
CC   Breed/subspecies: MRL/lpr.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4J73 ! KML1
SX   Female
AG   4M
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 6
//
RX   Patent=US5132222;
RA   Kanai Y., Awaya A.;
RT   "Established cell line, KML1-7, which produces B-cell differentiation
RT   factor (BCDF).";
RL   Patent number US5132222, 21-Jul-1992.
//
RX   PubMed=2197220; DOI=10.1016/0165-2478(90)90035-O;
RA   Kanai Y., Isonishi S., Katagiri T., Koizumi T., Miura K., Kurosawa Y.;
RT   "Early induction of anti-double-stranded DNA antibodies in lupus-prone
RT   MRL mice inoculated with Ly-24+ cells cloned from lymph node cells of
RT   an MRL/Mp-lpr/lpr mouse: possible effect of putative cytokines
RT   produced by cloned Ly-24+ cells.";
RL   Immunol. Lett. 24:49-55(1990).
//